Browse Category

NASDAQ:LNAI 5 November 2025 - 17 June 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Lunai Bioworks stock jumps after Nasdaq bid-price compliance filing

Lunai Bioworks stock jumps after Nasdaq bid-price compliance filing

Lunai Bioworks Inc. shares surged in early U.S. trading on Wednesday after a company filing showed Nasdaq had confirmed the biotechnology firm was back in compliance with the exchange’s $1 minimum bid-price rule, a key threshold for keeping a listing on the market. The stock was quoted at $4.65, with reported volume of 13.48 million shares, compared with average volume of 1.98 million.
17 June 2026
··
From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

From Crash to Breakthrough: Why Lunai Bioworks (LNAI) Is Suddenly on Investors’ Radar

Lunai Bioworks Inc. is a pre-clinical stage biotechnology company pioneering an unusual dual focus: AI-driven drug discovery and biodefense. The company’s mission is to “capture biological signals at scale, decode them with AI, and rapidly validate insights in model systems”, bridging cutting-edge computation with experimental biotechainvest.comainvest.com. In practical terms, Lunai is developing both therapeutic platforms and advanced diagnostics/screening tools, all underpinned by machine learning.
5 November 2025
···
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.